Co-founder & Precision Wellness Architect
Tyler Zollinger is a co-founder of CoGenetix and serves as the lead architect of its precision wellness framework. Tyler brings a systems-thinking perspective to how genetic data, biomarkers, and behavioral inputs can be unified into coherent, personalized wellness guidance. He is particularly interested in how emerging technologies can make precision medicine accessible rather than exclusive.
Glucose can remain normal while the body produces more insulin to maintain it. Fasting insulin may reveal part of that compensation, but interpretation is not standardized.
More health data does not automatically create more insight. AI is most useful when it separates meaningful trends from sensor error, normal variation, and context.
A biological-age result can be an interesting snapshot, but healthier aging is better assessed through a portfolio of validated, repeatable measures tied to function and disease risk.
The promise of wellness AI is not an all-knowing digital doctor. It is a disciplined feedback system that can organize data, detect patterns, and help people ask better questions while keeping medical decisions with qualified professionals.
Peptide therapy has long been practiced as an art, adjusting protocols based on clinical intuition and patient feedback. AI-assisted analysis of genetic, biomarker, and longitudinal response data is beginning to transform it into a precision science.
Peptide protocols are not one-size-fits-all. Genetic variants in growth hormone receptors, enzyme pathways, and inflammatory signaling help explain why two people on identical peptide programs can have strikingly different outcomes.
Most people choose supplements based on general wellness trends, friend recommendations, or marketing claims. A genetics-informed approach replaces guesswork with specific, evidence-based rationale for what your biology may actually benefit from.
Cardiovascular and metabolic health are deeply interconnected, and both are meaningfully influenced by genetic variation. A precision lens brings individual biology into focus for more effective prevention and optimization.
Precision wellness is at an inflection point. The convergence of accessible genomics, real-time biosensing, AI reasoning systems, and personalized therapeutics is creating a new category of health infrastructure that will define the next decade of individual health optimization.
You have one chronological age, but your biology may be younger or older than that number suggests. Understanding biological age, how it is measured, and what influences it opens a new window on personalized longevity.
GLP-1 medications work best as part of a structured program, not in isolation. Genetic testing, targeted nutrition, resistance training, and ongoing monitoring transform medication alone into a comprehensive metabolic health intervention.
Some patients achieve dramatic weight loss on GLP-1 medications; others see modest results. Understanding the biological, genetic, and behavioral factors behind this variability is critical for realistic expectations and personalized programs.
Human analytics, the systematic integration of genetic, biomarker, behavioral, and contextual data about an individual, represents the foundation for a new generation of personalized health guidance that goes far beyond single data points.
Weight and body composition are profoundly influenced by biology, but that biology is complex, polygenic, and highly interactive with environment. Understanding the science reframes both expectation and strategy.
Genetic tests have moved from research labs into everyday wellness routines. Understanding what they measure and where their limits lie, is the foundation for using them wisely.